Content area

|
|

Malignt neuroleptikasyndrom behandlet med elektrochokterapi

Forfatter(e)

Oona Nørgaard van Achter & Selvavathany Sivagurunathan

Regionspsykiatrien Vest, Herning

Ugeskr Læger 2020;182:V09200630

Reference: 
UgeskrLæger 2020;182:V09200630
Blad nummer: 
Neuroleptic malignant syndrome treated with electroconvulsive therapy

Oona Nørgaard van Achter & Selvavathany Sivagurunathan

Ugeskr Læger 2020;182:V09200630

Neuroleptic malignant syndrome (NMS) is a rare but severe complication to antipsychotic treatment. Both first-generation and second-generation antipsychotics can induce NMS. This is a case report of NMS induced by second-generation antipsychotic treatment with aripiprazole causing symptoms of rigidity, altered mental status, diaphoresis and creatine kinase elevation. A 27-year-old man was admitted to an ICU and underwent ECT treatment on day ten, 11 and 12 after presentation of the symptoms. There was significant symptom improvement after ECT treatment and full recovery after two weeks.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mads Bisgaard Bengtsen | 21/06
2 kommentarer
af John Brandt Brodersen | 21/06
1 Kommentar
af Thomas Tagmose Thomsen | 20/06
1 Kommentar
af Frederik Vilhelm Koch Federspiel | 20/06
9 kommentarer
af Thorkil Poulsen | 19/06
2 kommentarer
af Allan Birger Horn | 18/06
2 kommentarer
af Søren Visby | 14/06
2 kommentarer
af Rasmus Philip Nielsen | 13/06
2 kommentarer